...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Term sheet and enterprise valuation

"if it means waiting a year to get a massive buyout I am willing to wait"

A  full Year??what the heck for?? I strongly disagree -  both Zen & RVX have had many years of Pharma discussions etc etc

Donny has blown that/timeline smoke up our ... for far far to long!! He has been given more time,more compensation & more money than he deserves for running these 2 r&d companies. If he wants to jack arond more give us a NAS listing ASAP so some of us can finally abort this smug little general.

 

 

 

Share
New Message
Please login to post a reply